Skip to main content

Table 2 Comparison of epidemiological, demographic, immunologic and virological characteristics between Blastocystis- carrier (N = 39) and Blastocystis-free (N = 117) patients. Significant results were marked with *

From: Molecular characterization of Blastocystis subtypes in HIV-positive patients and evaluation of risk factors for colonization

  Blastocystis-carriers N (%) Blastocystis-free N (%) p-value
Gender, male 33 (82.0%) 84 (72.6%) 0.289
Age, years (mean ± SD) 44.71 ± 11.33 47.05 ± 12.37 0.06
Foreign origin 15 (38.46%) 25 (21.36%) 0.138
MSM 19 (48.71%) 31 (26.49%) 0.037*
Domestic animals 18 (46.15%) 56 (47.86%) 0.721
Travels 20 (51.28%) 47 (40.17%) 0.296
CD4 count, cells/ml, mean ± SD 637.43 ± 263.32 660.90 ± 414.35 0.823
CD4 count > 500 cells/ml 28 (71.79%) 69 (58.97%) 0.484
CD4 count 200–500 cells/ml 8 (20.51%) 33 (28.20%)
CD4 count < 200 cells/ml 3 (7.69%) 15 (12.82%)
HIV-RNA (< 37 copies/ml) 32 (82.05%) 80 (68.37%) 0.257
Naïve subjects 5 (12.82%) 18 (15.38%) 0.765
2NRTI + NNRTI 9 (23.07%) 26 (22.22%)
2NRTI + IP/r 7 (17.94%) 27 (23.07%)
2NRTI + INI 12 (30.76%) 24 (20.51%)
Dual therapy 6 (15.38%) 22 (18.80%)